BioCentury
ARTICLE | Financial News

Karyopharm closes $155M follow-on

May 18, 2018 7:14 PM UTC

Cancer company Karyopharm Therapeutics Inc. (NASDAQ:KPTI) raised $155 million through the sale of 10.5 million shares at $14.75 in an follow-on underwritten by J.P. Morgan, Jefferies, Leerink, Canacc...

BCIQ Company Profiles

Karyopharm Therapeutics Inc.